Volume 9, Issue 3, June 2018



Management of severe aplastic anaemia

Y. Serroukh, H. Claerhout, A. Janssens, T. Tousseyn, N. Boeckx, J. Maertens, T. Devos


Management of cutaneous T & B cell lymphomas: a comprehensive review

M. de Vicq de Cumptich, C. Springael, J. Somja, C. Bonnet, P. Heimann, U. Sass, A. Janssens, D. Bron

Updated BHS guidelines for the treatment of chronic lymphocytic leukaemia, mantle cell lymphoma and Waldenström macroglobulinemia anno 2018

A. Janssens, V. Vergote, V. Van Hende, D. Bron, A. Van Hoof


Vaccine response in patients receiving anti-B-cell targeted therapy

N. De Wilde, F. Offner

Management of immune thrombocytopenia in multiple sclerosis patients treated with alemtuzumab: a Belgian consensus

C. Lambert, B. Dubois, D. Dive, A. Lysandropoulos, D. Selleslag, L. Vanopdenbosch, V. Van Pesch, B. Van Wijmeersch, A. Janssens


Is it possible to predict who may never need treatment for B-CLL?

V. Galle, P. Vlummens, F. Offner